Tech Company Financing Transactions
Panome Bio Funding Round
Panome Bio, operating out of Louis, secured investment from Telegraph Hill Partners and BioGenerator.
Transaction Overview
Company Name
Announced On
3/15/2023
Transaction Type
Amount
Unknown
Round
Undisclosed
Investors
Telegraph Hill Partners (Lead Investor)
Proceeds Purpose
The financing will be used to develop new technologies and capabilities, expand laboratory facilities, and grow the Panome Bio team to service the increasing interest in metabolomics and proteomics data.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4340 Duncan Avenue St
Louis, MT 63110
USA
Louis, MT 63110
USA
Phone
Undisclosed
Website
Email Address
Overview
Panome Bio is your partner for a complete metabolomics workflow. Starting with clear instructions for collecting and shipping your samples, our team will make it simple to use metabolomics to interrogate your samples. We will handle all aspects of your sample prep. We work with you to select the best analysis type for your needs and subject your samples to cutting edge metabolomics technologies that provide robust and broad small molecule measurements. Further, we distill down the complex data into an easily digestible data analysis report that provides you with the complete picture of the small molecules in your sample as well as rigorous statistical analysis to give you actionable insights from your data.
Management Team
Browse more venture capital transactions:
Prev: 3/15/2023: Healium venture capital transaction
Next: 3/15/2023: Perspectum venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on every notable VC transaction. VC transactions on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs